The House Energy & Commerce Committee passed a drug-pricing transparency bill that would require drug makers to give HHS advance notice of price hikes with justification. The FAIR Drug Pricing Act was also included in the Senate health committee’s package on lowering health care costs, but senators may water down that bill before it gets to the Senate floor. The Fair Accountability and Innovative Research Drug Pricing Act of 2019 would force drug makers to submit a pricing information and...